Biapenem

比阿培南

Report date: 2023/03/22 14:29:54
NME

Base Information

Drug NameBiapenem
Drug Alias NameBiapenemum比阿配南OmegacinL-627CL-186815 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsUrinary Tract InfectionsRespiratory Tract InfectionsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date2001/10/02
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMeiji Seika Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiji Seika Pharmatech Co LtdNanjing Simcere Dongyuan Pharmaceutical Co Ltd
Inactive CompaniesRempex Pharmaceuticals IncTechnology Development Co Ltd Tianjin Medicine GroupBeijing Furuikangzheng Medicine Technology Research Institute
Active IndicationsBacterial Infections
Inactive IndicationsUrinary Tract InfectionsRespiratory Tract Infections

Other Information

ATC CodeJ01DH05
Related LinksWikipediaKEGG